Gsa Capital Partners LLP Meira G Tx Holdings PLC Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$4.21 - $5.81 $83,248 - $114,886	19,774 New	19,774 $83,000
Q1 2023 May 12, 2023	SELL	$5.04 - $8.6 $138,887 - $236,990	-27,557 Reduced 51.22%	26,247 $135,000
Q4 2022 Feb 13, 2023	SELL	$5.8 - $8.98 $23,339 - $36,135	-4,024 Reduced 6.96%	53,804 $351,000
Q3 2022 Nov 14, 2022	BUY	$7.55 - $11.25 $202,294 - $301,432	26,794 Added 86.34%	57,828 $486,000
Q2 2022 Aug 09, 2022	BUY	$6.8 - $14.23 $211,031 - $441,613	31,034 New	31,034 $235,000

100

45.4M

19.2K

31K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $283M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.